Camrelizumab/LenvatinibCerebral haemorrhage and immune-related pneumonia: 2 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72179-3

中图分类号：

学科分类号：

摘要：

引用

页码：70 / 70

共 50 条

[41] Ipilimumab/nivolumabHearing loss, posterior-uveitis and diffuse immune-related vitiligo: 2 case reports
Reactions Weekly, 2022, 1923 (1) : 268 - 268
[42] Lenvatinib/methylprednisolone/nivolumabImmune-related pneumonitis, immune-related skin toxicity and poor response: 2 case reports
Reactions Weekly, 2023, 1944 (1) : 332 - 332
[43] PembrolizumabImmune-related hepatitis and immune-related pneumonitis following off-label use: 2 case reports
Reactions Weekly, 2021, 1875 (1) : 283 - 283
[44] Immune globulinHeadache, myocardial infarction and pneumonia: 2 case reports
Reactions Weekly, 2015, 1567 (1) : 115 - 115
[45] Immune-related pneumonitis: A differential diagnosis of SARS-CoV-2 pneumonia
Nigen, B.
Chene, A. -l.
Liberge, R.
Sagan, C.
Blanc, F. -x.
REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (07) : 626 - 632
[46] Immune checkpoint inhibitors/prednisoloneGastrointestinal immune-related adverse events and cytomegalovirus enteritis: 9 case reports
Reactions Weekly, 2020, 1790 (1) : 130 - 130
[47] ImmunotherapiesAcute kidney injury and extrarenal immune-related adverse events : 3 case reports
Reactions Weekly, 2024, 2018 (1) : 242 - 242
[48] ImmunotherapiesEncephalomyelitis and immune-related adverse events affecting various organs: 10 case reports
Reactions Weekly, 2021, 1878 (1) : 279 - 279
[49] Ipilimumab/nivolumab/pembrolizumabPancreatic atrophy and immune-related adverse events: 31 case reports
Reactions Weekly, 2019, 1735 (1) : 162 - 162
[50] Immune-related gigantomastia: a case study
Lozito, Alessia
Gemelli, Maria
Micello, Donata
Vinci, Valeriano
Pelosi, Giuseppe
Ricotta, Riccardo
IMMUNOTHERAPY, 2023, 15 (13) : 1001 - 1007

← 1 2 3 4 5 →